Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01888562
Title Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

endometrial carcinoma

Therapies

Ponatinib

Age Groups: adult
Covered Countries

Additional content available in CKB BOOST